Abstract
Market analytics functions play a key role in helping pharmaceutical and
biotechnology companies make informed decisions, avoid risk and uncover
opportunities for growth. Although Market analytics insights can be vital to
corporate success, the function' s full value often remains unrealized.
This research examines how maximize the business value of analytics through
optimal structuring, staffing and positioning of analytics activities.
Executives can use this information to demonstrate business value and win the
recognition and resources needed to achieve and sustain high performance
levels.
This research is focused on major topic areas:
- (1) Hiring for Market Analytics Performance Excellence
- (2) Delivering High-Impact Services
- (3) Building Effective Relationships with Key Stakeholders
- (4) Structuring to Support Healthy Product Growth and
- (5) Winning Corporate Recognition and Support
Industries Profiled:
Pharmaceutical; Health Care; Consumer Products; Biotech
Companies Profiled:
Abbott Laboratories; Xanodyne Pharmaceuticals; Vertex Pharmaceuticals; Shire;
Sepracor; Sanofi-Aventis; Purdue Pharma; Ortho Biotech; Novartis; Medrad; Mead
Johnson; Genzyme; Eli Lilly; Eisai; DSM Pharmaceutical; Cubist
Pharmaceuticals; Boehringer Ingelheim; Aton Pharma; Amylin; Amgen; Alcon
View Cart
